O9387

Oxatomide

≥99%

• Synonym(s): 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one
• Empirical Formula (Hill Notation): C₂₇H₃₀N₄O
• CAS Number: 60607-34-3
• Molecular Weight: 426.55
• EC Number: 262-320-9
• MDL number: MFCD00211147
• UNSPSC Code: 51111800
• PubChem Substance ID: 24278615
• NACRES: NA.77

Properties

• Quality Level: 100
• assay: ≥99%
• form: powder
• color: white
• solubility: DMSO: soluble; ethanol: soluble
• originator: Johnson & Johnson
• SMILES string: O=C1Nc2ccccc2N1CCCN3CCN(CC3)C(c4ccccc4)c5ccccc5
• InChI: 1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)
• InChI key: BAINIUMDFURPJM-UHFFFAOYSA-N
• Gene Information: human ... DRD3(1814)

Description

General description

Oxatomide, a histamine H1-receptor antagonist, is bound at high levels to plasma proteins in human blood.

Biochem/physiol Actions

Oxatomide is an anti-allergy compound. It suppresses platelet activating factor (PAF)-induced bronchoconstriction and inhibits leukotriene production.

Oxatomide, found in several antihistamines, can suppress mast cell degranulation. It can be used as an alternative to individuals with allergic rhinitis who do not or poorly respond to more established antihistamines. Oxatomide exhibits both antihistamine and anti-inflammatory properties. It exhibits therapeutic effects against asthma and vulvar lichen sclerosus.

Features and Benefits

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves